Neovacs S.A. (EPA:ALNEV)
France · Delayed Price · Currency is EUR 0.6120
-0.0680 (-10.00%)
Aug 21, 2026, 5:35 PM CET
Neovacs Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -4.36 | -32.91 | -8.74 | -3.55 | -11.84 | -6.14 |
Depreciation & Amortization | 0.19 | 0.19 | 0.16 | 0.15 | 0.1 | 0.06 |
Loss (Gain) From Sale of Assets | - | 1.43 | 0.25 | 0 | 0.18 | - |
Asset Writedown & Restructuring Costs | -20.75 | 6.75 | 4.85 | 0.32 | 0 | - |
Other Operating Activities | 21.48 | 21.48 | - | - | -0.11 | 0.13 |
Change in Other Net Operating Assets | 0.34 | -0.54 | 1.56 | -1.37 | 1.76 | 0.31 |
Operating Cash Flow | -3.09 | -3.6 | -1.91 | -4.45 | -9.91 | -5.65 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Capital Expenditures | -0.02 | -0.08 | -0.2 | -0.15 | -0.35 | -0.21 |
Sale (Purchase) of Intangibles | - | - | -0 | -0 | -0 | - |
Investment in Securities | -1.41 | 1.53 | -10.87 | -31.4 | -18.46 | -0.02 |
Other Investing Activities | 0 | 0 | -0 | - | - | - |
Investing Cash Flow | -1.42 | 1.45 | -11.08 | -31.56 | -18.81 | -0.22 |
Financing Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Long-Term Debt Issued | - | 1.09 | 6.19 | 9 | 46.85 | 14 |
Long-Term Debt Repaid | - | -1.52 | -5.05 | -8.83 | -46.16 | -13.76 |
Net Debt Issued (Repaid) | -0.23 | -0.43 | 1.14 | 0.17 | 0.69 | 0.24 |
Issuance of Common Stock | 4.59 | 2.17 | 5.65 | 9.81 | 51.06 | 14.41 |
Other Financing Activities | -0.03 | -0.03 | - | - | - | - |
Financing Cash Flow | 4.33 | 1.7 | 6.79 | 9.99 | 51.75 | 14.65 |
Net Cash Flow
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Miscellaneous Cash Flow Adjustments | - | - | -0 | 0 | - | 0 |
Net Cash Flow | -0.19 | -0.45 | -6.2 | -26.02 | 23.03 | 8.78 |
Free Cash Flow
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Free Cash Flow | -3.11 | -3.68 | -2.12 | -4.6 | -10.26 | -5.86 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -1561.34% | -848.26% | -396.80% | -413782.37% | -45498.69% | -19665.26% |
Free Cash Flow Per Share | - | - | - | -0.02 | -5.15 | -0.01 |
Levered Free Cash Flow | -3.82 | -2.59 | -5.29 | -3.5 | -3.7 | -2.05 |
Unlevered Free Cash Flow | -3.41 | -2.59 | -5.29 | -3.5 | -3.7 | -2.05 |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Change in Working Capital | 0.34 | -0.54 | 1.56 | -1.37 | 1.76 | 0.31 |